Classical homocystinuria: Vascular risk and its prevention
Author:
- 1 March 2003
- journal article
- review article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 26 (2-3) , 259-265
Abstract
Summary. Homocystinuria due to cystathionine β‐synthase deficiency is the second most treatable aminoacidopathy. The reported incidence varies from 1 in 344 000 worldwide to 1 in 65 000 in Ireland. Untreated patients with homocystinuria have severe hyperhomocysteinaemia. Amongst its pathological sequelae, which include mental retardation, ectopia lentis and osteoporosis, vascular events remain the major cause of morbidity and mortality in untreated patients. Recognized modalities of treatment include pyridoxine, in combination with folic acid and vitamin B12; methionine‐restricted, cystine‐supplemented diet; and betaine. The natural history of vascular events is such that half will have an event before age 30 years and there is a predicted one event per 25 years at the time of maximal risk. In 158 patients with 2822 patient‐years of treatment, there would be a predicted 112 events if left untreated, but instead only 17 vascular events were recorded during treatment (relative risk 0.09, 95% CI 0.036 to 0.228; p<0.0001). Appropriate chronic treatment to lower hyperhomocysteinaemia is effective in reducing the potentially life‐threatening vascular risk in patients with homocystinuria. These findings may also have relevance to the significance of mild hyperhomocysteinaemia that is commonly found in patients with premature vascular disease.Keywords
This publication has 28 references indexed in Scilit:
- Vascular Outcome in Patients With Homocystinuria due to Cystathionine β-Synthase Deficiency Treated ChronicallyArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Vascular Complications of Severe Hyperhomocysteinemia in Patients with Homocystinuria Due to Cystathionine β-Synthase Deficiency: Effects of Homocysteine-Lowering TherapySeminars in Thrombosis and Hemostasis, 2000
- Homocysteine and Its Disulfide DerivativesArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Molecular basis of phenotype expression in homocystinuriaJournal of Inherited Metabolic Disease, 1994
- Dietary treatment of homocystinuria.Archives of Disease in Childhood, 1966
- HomocystinuriaThe Journal of Pediatrics, 1965
- Homocystinuria due to Cystathionine Synthetase Deficiency: The Mode of InheritanceScience, 1964
- Homocystinuria: An Enzymatic DefectScience, 1964
- The identification of homocystine in the urineBiochemical and Biophysical Research Communications, 1962
- Metabolic Abnormalities Detected in a Survey of Mentally Backward Individuals in Northern IrelandArchives of Disease in Childhood, 1962